By Svatopluk Nemecek and Alexander Kwasniewski for U.S. News. From April 19–21, global leaders will meet for the first time in 18 years to debate global drug policy at the U.N. General Assembly Special Session on the World Drug Problem in New York. As soon as this week, the 59th session of the Commission on Narcotic Drugs will have the opportunity to decide whether the U.N. session will truly be “special” in achieving tangible results – or not.
If it is special in bringing strong outputs based on reality, the global regime will incorporate human rights and public health into current drug policies. Weak and blurred outputs would mean that the same regime has proved unable to adapt itself to the changing world and is doomed to collapse.